Kiniksa Pharmaceuticals International, plc

10-Q Quarter ended 2026-06-30 Jul 28, 2026 8-K Results of operations (earnings release) Jul 28, 2026 8-K Shareholder vote results May 29, 2026 8-K Entered a material agreement May 26, 2026 8-K Director or officer change May 1, 2026 10-Q Quarter ended 2026-03-31 Apr 28, 2026 8-K Results of operations (earnings release) Apr 28, 2026 10-K Fiscal year ended 2025-12-31 Feb 24, 2026 8-K Results of operations (earnings release) Feb 24, 2026 8-K Director or officer change Jan 14, 2026 8-K Results of operations (earnings release) Jan 12, 2026 10-Q Quarter ended 2025-09-30 Oct 28, 2025 8-K Results of operations (earnings release) Oct 28, 2025 8-K Regulation FD disclosure Sep 3, 2025 10-Q Quarter ended 2025-06-30 Jul 29, 2025 8-K Results of operations (earnings release) Jul 29, 2025 8-K Regulation FD disclosure Jun 5, 2025 8-K Shareholder vote results Jun 3, 2025 10-Q Quarter ended 2025-03-31 Apr 29, 2025 8-K Results of operations (earnings release) Apr 29, 2025 8-K Director or officer change Apr 23, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Terminated a material agreement; Results of operations (earnings release); Exit or disposal costs Feb 25, 2025 8-K Results of operations (earnings release) Jan 13, 2025 10-Q Quarter ended 2024-09-30 Oct 29, 2024 8-K Results of operations (earnings release) Oct 29, 2024 8-K Director or officer change Oct 7, 2024 10-Q Quarter ended 2024-06-30 Jul 25, 2024 8-K Results of operations (earnings release) Jul 23, 2024 8-K Entered a material agreement Jun 25, 2024 8-K Other events Jun 14, 2024 8-K Shareholder vote results Jun 5, 2024 10-Q Quarter ended 2024-03-31 Apr 25, 2024 8-K Results of operations (earnings release) Apr 23, 2024 8-K Regulation FD disclosure Apr 2, 2024 8-K Other events Mar 29, 2024 10-K Fiscal year ended 2023-12-31 Feb 28, 2024 8-K Results of operations (earnings release) Feb 28, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jan 4, 2024 10-Q Quarter ended 2023-09-30 Nov 2, 2023